Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections

HIV Clin Trials. 2002 Jul-Aug;3(4):333-49. doi: 10.1310/3dap-k96v-qpan-213l.
No abstract available

Publication types

  • Congress

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / immunology
  • AIDS Vaccines / therapeutic use
  • AIDS-Related Opportunistic Infections / complications*
  • AIDS-Related Opportunistic Infections / drug therapy
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / immunology
  • Anti-HIV Agents / therapeutic use
  • Dideoxynucleosides / adverse effects
  • Drug Hypersensitivity
  • HIV Fusion Inhibitors / pharmacology
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / genetics
  • HIV Infections / immunology
  • HIV Integrase Inhibitors / pharmacology
  • HLA-B Antigens / genetics
  • HLA-B Antigens / immunology
  • Hepatitis C / complications
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology
  • Hepatitis C / therapy
  • Humans
  • Immunotherapy
  • Receptors, Chemokine / antagonists & inhibitors
  • Receptors, Chemokine / metabolism
  • Tuberculosis / complications
  • Tuberculosis / drug therapy

Substances

  • AIDS Vaccines
  • Anti-HIV Agents
  • Dideoxynucleosides
  • HIV Fusion Inhibitors
  • HIV Integrase Inhibitors
  • HLA-B Antigens
  • HLA-B57 antigen
  • Receptors, Chemokine
  • abacavir